Market closedNon-fractional

VBI Vaccines/VBIV

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About VBI Vaccines

VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.

Ticker

VBIV

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Cambridge, United States

Employees

135

VBI Vaccines Metrics

BasicAdvanced
$17M
Market cap
-
P/E ratio
-$4.30
EPS
1.89
Beta
-
Dividend rate
$17M
1.89
0.34
0.165
-20.779
-927.602
-5.63%
-29.15%
-419.59%
1.237
-2.65
-0.34
-0.226
553.09%
-69.13%
115.00%
-15.19%

What the Analysts think about VBI Vaccines

Analyst Ratings

Majority rating from 1 analysts.
Buy

VBI Vaccines Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,491.66% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.2M
50.00%
Net income
-$18M
-∞%
Profit margin
-1,491.66%
-∞%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for VBI Vaccines stock?

VBI Vaccines (VBIV) has a market cap of $17M as of July 23, 2024.

What is the P/E ratio for VBI Vaccines stock?

The price to earnings (P/E) ratio for VBI Vaccines (VBIV) stock is 0 as of July 23, 2024.

Does VBI Vaccines stock pay dividends?

No, VBI Vaccines (VBIV) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next VBI Vaccines dividend payment date?

VBI Vaccines (VBIV) stock does not pay dividends to its shareholders.

What is the beta indicator for VBI Vaccines?

VBI Vaccines (VBIV) has a beta rating of 1.89. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell VBI Vaccines stock

Buy or sell VBI Vaccines stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing